If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,060.00
Ask:
1,064.00
Spread: 4.00 (0.377%)
Market Cap: £151.30b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Prospectus Exemption

23 Apr 2026 07:40

RNS Number : 6416B
Banco Santander S.A.
23 April 2026
 

 

 

 

Banco Santander, S.A. ("Banco Santander"), in accordance with the provisions of securities market legislation, hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

In connection with the issuance of up to 334,809,216 new ordinary shares of Banco Santander in the context of its acquisition of Webster Financial Corporation, it is hereby noted that Banco Santander is not required to publish, and will not publish, a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017, on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). Banco Santander has elected to rely on the exemptions set forth in Article 1(4)(da) and Article 1(5)(a) of the Prospectus Regulation.

 

To that end, Banco Santander has today published on its corporate website (www.santander.com) an exemption document (the "Exemption Document"), in accordance with the requirements of Annex IX of the Prospectus Regulation. The Exemption Document has been filed with the National Securities Market Commission (Comisión Nacional del Mercado de Valores, "CNMV") and made available to the public in accordance with Article 21(2) of the Prospectus Regulation. The Exemption Document is available at https://www.santander.com/content/dam/santander-com/es/documentos/aumento-de-capital-para-la-adquisicion-de-webster/exemption-document.pdf

 

The Exemption Document does not constitute a prospectus within the meaning of the Prospectus Regulation and is not subject to review and approval under Article 20 thereof. Accordingly, it has not been reviewed or approved by the CNMV.

 

 

Boadilla del Monte (Madrid), 23 April 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCIJMFTMTJTMIF
Date   Source Headline
26th Mar 20217:00 amRNSAnalysts call on Santander Mexico tender offer
26th Mar 20217:00 amRNSInformation on payment of dividends
19th Mar 202111:19 amRNSAdditional notice to the call to the AGM
11th Mar 20215:08 pmRNSDirector/PDMR Shareholding
11th Mar 20215:07 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
23rd Feb 20214:13 pmRNSNotice of AGM
23rd Feb 20214:00 pmRNSAnnual Financial Report
18th Feb 20215:32 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding
18th Feb 20215:27 pmRNSDirector/PDMR Shareholding
18th Feb 20215:17 pmRNSDirector/PDMR Shareholding
18th Feb 20215:17 pmRNSDirector/PDMR Shareholding
18th Feb 20215:15 pmRNSDirector/PDMR Shareholding
18th Feb 20215:14 pmRNSDirector/PDMR Shareholding
18th Feb 20215:14 pmRNSDirector/PDMR Shareholding
18th Feb 20215:13 pmRNSDirector/PDMR Shareholding
18th Feb 20215:12 pmRNSDirector/PDMR Shareholding
18th Feb 20215:12 pmRNSDirector/PDMR Shareholding
18th Feb 202111:05 amRNSForm 8.3 - RSA Insurance Group Plc
3rd Feb 20217:00 amRNS2020 Results - Press release
3rd Feb 20217:00 amRNS2020 results report & analyst presentation
2nd Feb 20212:56 pmRNSNotice of 2020 Results
22nd Dec 20205:18 pmRNSChanges in the composition of the Board
22nd Dec 20207:18 amRNSTotal redemption and cancellation of bonds
18th Dec 202010:12 amRNSDirector/PDMR Shareholding
14th Dec 20203:54 pmRNSDirector/PDMR Shareholding
14th Dec 20203:54 pmRNSDirector/PDMR Shareholding
11th Dec 20201:05 pmRNSDirector/PDMR Shareholding
11th Dec 202012:53 pmRNSDirector/PDMR Shareholding
11th Dec 202012:52 pmRNSDirector/PDMR Shareholding
11th Dec 202012:52 pmRNSDirector/PDMR Shareholding
11th Dec 202012:52 pmRNSDirector/PDMR Shareholding
11th Dec 202012:51 pmRNSDirector/PDMR Shareholding
11th Dec 202012:50 pmRNSDirector/PDMR Shareholding
11th Dec 202012:50 pmRNSDirector/PDMR Shareholding
11th Dec 202012:50 pmRNSDirector/PDMR Shareholding
11th Dec 202012:48 pmRNSDirector/PDMR Shareholding
11th Dec 202012:48 pmRNSDirector/PDMR Shareholding
11th Dec 202012:47 pmRNSDirector/PDMR Shareholding
11th Dec 202012:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.